Table 3.
Comparison of the recombinant in-house Dot Blot Assay results with results of commercial Western Blot Assay as interpreted by various criteria.
| Sample Group (No. Of Specimens) | Results (%) of test as interpreted by indicated criteria† | |||
|---|---|---|---|---|
| Dot Blot | Western Blot | |||
| CDC | ASTPHLD | CRSS | ||
| Seronegative | 0 pos. | 0 pos. | 0 pos. | 0 pos. |
| 2.2 ind. | 2.8 ind. | 2.8 ind. | 2.8 ind. | |
| 97.8 neg. | 97.2 neg. | 97.2 neg. | 97.2 neg. | |
| Seropositive | 97.6 pos. | 96.6 pos. | 96.8 pos. | 96.8 pos. |
| 2.4 ind. | 3.4 ind. | 3.2 ind. | 3.2 ind. | |
| 0 neg. | 0 neg. | 0 neg. | 0 neg. | |
† DBA, Dot Blot Assay; pos, Positive; ind, Indeterminate; neg, Negative.